NCM · Biotechnology

CRVO (CRVO) Stock

$2.57 -2.28% NCM: CRVO Healthcare

Valuation

MetricValue
Price$2.57
Market Cap$23.79M
P/E Ratio-1.09
P/B Ratio1.67
P/S Ratio87.83
EPS (TTM)$0.00
52-Week High$13.13
52-Week Low$2.13
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-150.00%
ROA-117.39%
ROCE-155.56%
Gross Margin0.00%
Operating Margin0.00%
Net Margin-93.12%
Debt/Equity0.00
Current Ratio4.60

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-25.0M$-3.0M$-8.0M$-18.0M$-28.0M
Net Profit$-24.0M$-6.0M$-2.0M$-16.0M$-27.0M
EPS$-18.51$-11.20$-0.82$-2.02$-2.98
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$38.0M$4.0M$10.0M$43.0M$23.0M
Total Liabilities$3.0M$13.0M$3.0M$4.0M$5.0M
Cash$37.0M$4.0M$8.0M$9.0M$8.0M
Borrowings$0$12.0M$0$0$0

Latest News

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB) GlobeNewswire · Jul 14, 2026 CervoMed Completes Enrollment in Phase 2a Study of Neflamapimod in Frontotemporal Dementia MT Newswires · Jul 9, 2026 CervoMed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia GlobeNewswire · Jul 9, 2026 CervoMed Files for Resale of Common Shares MT Newswires · Jul 6, 2026 CervoMed Showcases Leadership in Advancing the Treatment and Care of Dementia with Lewy Bodies at the Alzheimer's Association International Conference (AAIC) 2026 GlobeNewswire · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-15.0M$-3.0M$-7.0M$-17.0M$-23.0M
Investing Cash Flow$0$0$0$-29.0M$18.0M
Financing Cash Flow$-4.0M$0$10.0M$0$0
Net Cash Flow$19.0M$-33.0M$4.0M$1.0M$-1.0M
Free Cash Flow$-15.0M$-3.0M$-7.0M$-17.0M$-23.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-97.33%
Quick Ratio6.65
Interest Coverage—
Return 1Y-57.48%
Return 3Y-32.00%
Return 5Y-92.82%

Ownership

Insiders Held29.55%
Institutions Held19.11%
Institutions Float Held27.13%
Institutional HolderSharesReport Date
Morgan Stanley739,8922026-03-31
Vanguard Capital Management LLC316,2022026-03-31
Millennium Management Llc208,9082026-03-31
Geode Capital Management, LLC74,3712026-03-31
Renaissance Technologies, LLC63,9042026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACET $9.26 +6.44% -0.46 $86.56M 0.00%
ADAGAdagene Inc. $3.67 +1.66% -7.78 $138.17M 0.00%
FBIO $2.68 -2.01% 0.91 $89.03M 0.00%
GANX $1.77 -1.67% -2.70 $75.50M 0.00%
LITS $0.99 +0.86% -0.35 $33.82M 0.00%

About CRVO

CRVO is led by CEO John J. Alam, employs 15 people, headquartered in US, publicly traded since 2008.

CRVO stock trades at $2.57 with a market capitalization of $23.79M. The stock is valued at a price-to-earnings (P/E) ratio of -1.09, price-to-book of 1.67, price-to-sales of 87.83. Over the past 52 weeks the stock has ranged between $2.13 and $13.13, and currently trades 80.4% below its 52-week high.

On profitability, CRVO generates a return on equity (ROE) of -150.00%, return on capital employed of -155.56%, an operating margin of 0.00%, a net profit margin of -93.12%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides